AI
GSK icon

Ariel Investments’s GSK GSK Stock Holding History

Ariel Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-55,392
Closed -$2.05M – 119
2023
Q4 		$2.05M Sell
55,392
-86,105
-61% -$3.09M 0.02% 102
2023
Q3 		$5.13M Sell
141,497
-30,180
-18% -$1.07M 0.05% 90
2023
Q2 		$6.12M Sell
171,677
-13,691
-7% -$491K 0.06% 92
2023
Q1 		$6.6M Buy
185,368
+80
+0% +$2.8K 0.06% 91
2022
Q4 		$6.51M Buy
185,288
+15,727
+9% +$524K 0.07% 90
2022
Q3 		$4.99M Sell
169,561
-40,911
-19% -$1.55M 0.05% 94
2022
Q2 		$11.5M Buy
210,472
+13,793
+7% +$761K 0.11% 84
2022
Q1 		$10.7M Sell
196,679
-5,600
-3% -$304K 0.1% 88
2021
Q4 		$11.2M Sell
202,279
-6,474
-3% -$337K 0.09% 89
2021
Q3 		$9.97M Hold
208,753
– – 0.09% 90
2021
Q2 		$10.4M Sell
208,753
-134,234
-39% -$6.45M 0.1% 91
2021
Q1 		$15.3M Sell
342,987
-120,119
-26% -$5.45M 0.15% 86
2020
Q4 		$21.3M Sell
463,106
-229,247
-33% -$10.5M 0.24% 78
2020
Q3 		$32.6M Sell
692,353
-126,411
-15% -$6.33M 0.47% 58
2020
Q2 		$41.7M Sell
818,764
-115,420
-12% -$5.92M 0.64% 49
2020
Q1 		$44.2M Buy
934,184
+254
+0% +$13.5K 0.78% 47
2019
Q4 		$54.9M Sell
933,930
-211,777
-18% -$11.8M 0.69% 49
2019
Q3 		$61.1M Sell
1,145,707
-34,557
-3% -$1.78M 0.81% 47
2019
Q2 		$59M Sell
1,180,264
-148,282
-11% -$7.44M 0.74% 50
2019
Q1 		$69.4M Hold
1,328,546
– – 0.86% 44
2018
Q4 		$63.5M Sell
1,328,546
-35,556
-3% -$1.75M 0.88% 43
2018
Q3 		$68.5M Hold
1,364,102
– – 0.76% 49
2018
Q2 		$68.7M Sell
1,364,102
-53,138
-4% -$2.68M 0.77% 50
2018
Q1 		$69.2M Sell
1,417,240
-6,473
-0.5% -$301K 0.79% 49
2017
Q4 		$63.1M Buy
1,423,713
+75,817
+6% +$3.5M 0.71% 52
2017
Q3 		$68.4M Buy
1,347,896
+30,979
+2% +$1.57M 0.79% 52
2017
Q2 		$71M Hold
1,316,917
– – 0.84% 49
2017
Q1 		$69.4M Hold
1,316,917
– – 0.82% 48
2016
Q4 		$63.4M Buy
1,316,917
+30,759
+2% +$1.52M 0.75% 53
2016
Q3 		$69.3M Hold
1,286,158
– – 0.84% 45
2016
Q2 		$69.7M Buy
1,286,158
+19,828
+2% +$1.04M 0.87% 46
2016
Q1 		$64.2M Buy
1,266,330
+84,749
+7% +$4.22M 0.77% 52
2015
Q4 		$59.6M Buy
1,181,581
+15,051
+1% +$767K 0.71% 53
2015
Q3 		$56.1M Buy
1,166,530
+194,988
+20% +$10.2M 0.7% 53
2015
Q2 		$50.6M Buy
971,542
+135,596
+16% +$7.63M 0.57% 55
2015
Q1 		$48.2M Buy
835,946
+8
+0% +$459 0.54% 54
2014
Q4 		$44.7M Buy
835,938
+31,431
+4% +$1.76M 0.52% 57
2014
Q3 		$46.2M Buy
804,507
+13,489
+2% +$827K 0.6% 51
2014
Q2 		$52.9M Buy
791,018
+261,298
+49% +$17.7M 0.65% 54
2014
Q1 		$35.4M Buy
529,720
+192,759
+57% +$13M 0.43% 65
2013
Q4 		$22.5M Buy
336,961
+227,886
+209% +$14.8M 0.28% 77
2013
Q3 		$6.84M Buy
109,075
+77,582
+246% +$4.99M 0.1% 105
2013
Q2 		$1.97M Buy
+31,493
New +$2M 0.03% 124

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ariel Investments's GSK Position: Q1 2024 in Review

Ariel Investments sold out of GSK (GSK) in Q1 2024, closing a stake of 55,392 shares — an estimated $2.05M sold.

Ariel Investments first reported a position in GSK in Q2 2013 and held it in 43 quarters. The position peaked at $71M in Q2 2017. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Ariel Investments reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Ariel Investments sold 55,392 GSK shares in Q1 2024, an estimated $2.05M.
  • Ariel Investments first reported a position in GSK in Q2 2013 and held it in 43 quarters.
  • Ariel Investments's GSK position peaked at $71M in Q2 2017.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Ariel Investments's 13F filing for Q1 2024, filed 14 May 2024.